Today: 9 June 2026
Browse Category

NASDAQ:NUVB 20 November 2025 - 12 January 2026

Nuvation Bio stock slides nearly 18% as Eisai deal, early IBTROZI sales hit screens

Nuvation Bio stock slides nearly 18% as Eisai deal, early IBTROZI sales hit screens

Nuvation Bio shares fell 17.7% to $6.62 Monday after announcing a licensing deal with Eisai and releasing initial sales data for its lung-cancer drug. Eisai will pay €50 million upfront for rights outside the U.S., China, and Japan, with further milestone payments possible. Fourth-quarter Ibtrozi sales met estimates, but investors appeared cautious on future prescription growth.
12 January 2026
····
Nuvation Bio stock falls as UBS starts coverage; NUVB investors eye JPM conference next week

Nuvation Bio stock falls as UBS starts coverage; NUVB investors eye JPM conference next week

Nuvation Bio shares fell 4.7% to $8.05 Friday afternoon, underperforming biotech peers. UBS began coverage at Neutral with a $10 target, while RBC raised its target to $9 and reiterated Outperform. CEO David Hung is set to present at the J.P. Morgan Healthcare Conference on Jan. 13. Investors await early March results for updates on IBTROZI’s launch and pipeline spending.
9 January 2026
·
Nuvation Bio (NUVB) Rockets to 3‑Year High as Wall Street Lifts Price Targets on IBTROZI Momentum – November 20, 2025

Nuvation Bio (NUVB) Rockets to 3‑Year High as Wall Street Lifts Price Targets on IBTROZI Momentum – November 20, 2025

Nuvation Bio shares surged 49% to $7.15 on November 20, 2025, hitting a three-year high after Q3 revenue of $13.1 million nearly doubled analyst estimates. Uptake of its lung-cancer drug IBTROZI drove $7.7 million in U.S. sales and 204 new patient starts. Multiple analysts raised price targets, with the average now at $10.13. Trading volume spiked, extending a multi-day rally.
20 November 2025
·

Stock Market Today

  • U.S. National Debt Surpasses $100 Trillion, Reaches $1 Million Per Household
    June 9, 2026, 3:42 PM EDT. The effective U.S. national debt has surged past $100 trillion, hitting an unprecedented 400% of annual gross domestic product (GDP). This milestone equates to roughly $1 million owed per U.S. household. Experts express concern over the unsustainable debt-to-GDP ratio, which indicates the country's debt is four times its yearly economic output. Despite the scale, public reaction remains muted as policymakers grapple with long-term fiscal challenges.

Latest articles

Elong Power Stock Rips 58%, Small Nasdaq Battery Play Goes Wild

Elong Power Stock Rips 58%, Small Nasdaq Battery Play Goes Wild

9 June 2026
Elong Power shares soared 58.3% to $1.22 in heavy Nasdaq trading, with volume topping 123 million, after a recent $6 million unit offering at $1.30 and a March 1-for-80 reverse split; despite the rally, the stock remained below the recent offering price, with filings showing a $5.57 million net loss for 2025, a $14 million working-capital deficit, and warnings of possible further dilution if more capital is needed.
Marathon Digital Shares Fall as Bitcoin Move Renews Focus on AI Strategy

Marathon Digital Shares Fall as Bitcoin Move Renews Focus on AI Strategy

9 June 2026
MARA shares plunged 4.3% to $13.19 as bitcoin slipped below $62,000, highlighting that despite efforts to pivot toward AI and data-center infrastructure, the stock remains tightly tied to bitcoin’s price, with recent earnings showing revenue and bitcoin holdings down sharply and ongoing risks if crypto weakness persists.
UiPath Falls Again as AI Stocks Face Selling

UiPath Falls Again as AI Stocks Face Selling

9 June 2026
UiPath shares slid 5% to $10.63 as investors dumped AI-linked tech stocks despite the company posting its first-ever GAAP profit and raising full-year guidance, with market pressure and doubts about rapid AI-driven growth weighing on the stock.
XRP price today: Ripple token bounces as DTCC listing and Iran war headlines steer crypto traders

XRP Price Holds $1.10 as Key Level for Traders

9 June 2026
XRP slid 2.6% to $1.14 as crypto markets lost momentum, leaving the token just above key $1.10 support defended after last week’s four-month lows; traders are watching $1.13-$1.14 as support and $1.15-$1.20 as resistance, with broader risk-off sentiment and weak ETF inflows pressuring prices, while a break below $1.10 could signal further downside.
Ondas Stock Slides as Fresh Share-Resale Filing Tests Drone Rally

Ondas Stock Slides as Fresh Share-Resale Filing Tests Drone Rally

9 June 2026
Ondas Inc. shares fell 6.7% to $9.61 after filing a prospectus supplement for the resale of 2.7 million shares tied to its Omnisys acquisition, raising supply concerns as investors focus on defense orders and recent acquisitions; the block represents about 0.5% of shares outstanding and follows a volatile session with high trading volume.
Go toTop